Correlation Engine 2.0
Clear Search sequence regions


  • blood (3)
  • hyaluronan (10)
  • lymph (8)
  • medicines (1)
  • molecular weight (1)
  • portal vein (1)
  • rats (2)
  • rats wistar (1)
  • Sizes of these terms reflect their relevance to your search.

    Hyaluronan (HA) has been widely used in medicines, cosmetics and supplements for health and beauty maintenance. Oral administration is the most desirable and convenient means for consumers. The intestine plays an important role in immune system. We hypothesized that orally administered HA would be transferred to both blood and lymph. In this study, we investigated how orally administered HA was absorbed from the gastrointestinal tract and how much HA was incorporated. Four HA formulations, HA-2,000, 8,000, 50,000 and 300,000, were administered to rats, and concentrations of HA in blood and lymph were determined. In the HA-2,000 group, the HA plasma concentration increased after oral administration. The highest lymph concentration of HA was also obtained by administration of HA-2,000. The plasma and lymph concentrations slightly increased after oral administration in the HA-8,000 group. On the other hand, little absorption was found in the HA-50,000 and 300,000 groups. It is speculated that smaller molecules of HA are more easily absorbed. HA-2,000 was absorbed mainly through the portal vein and through the lymph in gastrointestinal absorption. This is the first report showing that HAs, large molecular weight and water-soluble molecules, after oral administration are transferred not only into blood but also into lymph. Copyright © 2020 Elsevier B.V. All rights reserved.

    Citation

    Yuki Sato, Tatsuru Joumura, Yoh Takekuma, Mitsuru Sugawara. Transfer of orally administered hyaluronan to the lymph. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 2020 Sep;154:210-213

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32681965

    View Full Text